IB
iShares Biotechnology ETF (IBB)
NASDAQ·Financial Services·Asset Management
$170.77
+0.16%
Mkt Cap $8.40B
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$217.35
Range $147.42 – $255.15
Implied Upside
+27.3%
Consensus $217.35 vs current $170.77